Vedanta Limited has scheduled its 61st Annual General Meeting for July 14, 2026, with the Register of Members and Share Transfer Books remaining closed from July 9-13, 2026 for AGM purposes. The company has been actively advancing its strategic initiatives, including the acquisition of Incab Industries Limited under the Corporate Insolvency Resolution Process for ₹590.5 crore, which adds power cable manufacturing capabilities. Additionally, Vedanta reduced its shareholding in Hindustan Zinc Limited from 63.42% to 60.71% through an Offer for Sale, generating proceeds of approximately ₹6,292 crore. The company continues to advance its "Transforming for Good" ESG agenda across three pillars, with key FY 2025-26 highlights including renewable energy consumption increased by over 50% to 3.97 billion units and GHG intensity reduced to 5.51 tCO₂e/MT of metal.
New India Assurance Company Ltd emerged as the top performer in BSE's 'A' group, rising 2.29% to ₹152.10 following strong Q3 FY26 results. The stock witnessed exceptional trading activity with volume surging 84.52 times to 720.99 lakh shares by 14:14 IST on NSE, compared with a two-week average daily volume of 8.53 lakh shares. This surge was driven by the company's robust financial performance, with consolidated net profit rising 8.9% YoY to ₹379.95 crore in Q3 FY26, compared with ₹349.05 crore in the corresponding quarter last year.
Cohance Lifesciences Ltd secured the second position with a 20% surge to ₹487.50, as reported by Business Standard. The stock demonstrated exceptional trading activity with volume jumping 32 times to 2.13 crore shares compared with an average volume of 6.59 lakh shares in the past two weeks. Blue Jet Healthcare Ltd followed with significant gains, while Allied Blenders & Distillers Ltd and Genus Power Infrastructures Ltd also featured among the top performers in the 'A' group segment.
The 'A' group stocks showed unprecedented trading interest across all top performers. As reported by Business Standard, Jain Irrigation Systems Ltd recorded 7.85 lakh shares traded against an average of 2.62 lakh shares in the past month, indicating heightened investor interest. Aarti Pharmalabs Ltd saw 60,419 shares traded compared to its average daily volume of 12,632 shares, while BASF India Ltd recorded 5,862 shares traded versus its average of 1,636 shares. These trading volumes suggest strong market participation in the 'A' group segment, with Cohance Lifesciences leading with volumes jumping 32 times above normal levels.
The pharmaceutical sector emerged as the standout performer across Indian markets, with Nifty Pharma gaining over 1% and Nifty Healthcare almost 1% higher. According to latest reports, Dr. Reddy's Laboratories was the top gainer, rising over 2% and marking its third straight session of gains. Sun Pharmaceutical Industries, Cipla, and Apollo Hospitals Enterprise were 0.8-1.7% higher, while Laurus Labs, Torrent Pharmaceuticals, Mankind Pharma, Alkem Laboratories, Glenmark Pharmaceuticals, and Aurobindo Pharma gained 1.7-2.5% in the Nifty 200 index. The sectoral strength was driven by positive developments including the US FDA seeking assistance from Indian drug manufacturers for Ifosfamide production.
